List view / Grid view
When Enzymatic Therapy stopped outsourcing and built its own FDA-approved manufacturing facility, the goal was to improve product quality, streamline production, and ramp up sales growth. A crucial step was selecting the right pharmaceutical sieving equipment to remove any agglomerates, oversize particles or contaminants from incoming raw dry materials.
25 April 2016 | By Victoria White, Digital Content Producer
The designation is based on results of a Phase III trial evaluating Opdivo versus investigator’s choice of therapy in patients with SCCHN...
25 April 2016 | By Victoria White, Digital Content Producer
Descovy is the first new HIV backbone approved in Europe in more than a decade and represents an important advance in addressing the needs of patients...
25 April 2016 | By Victoria White, Digital Content Producer
New research is providing the foundation to apply criminology theory to preventing the production and sale of counterfeit medicines...
22 April 2016 | By Victoria White, Digital Content Producer
EAGLES compared the neuropsychiatric safety and efficacy of varenicline and bupropion to placebo and nicotine patch to help people quit smoking...
22 April 2016 | By Victoria White, Digital Content Producer
TapImmune plans to initiate a Phase II trial of TPIV 200 in combination with AstraZeneca’s durvalumab in patients with platinum-resistant ovarian cancer...
22 April 2016 | By Victoria White, Digital Content Producer
New data demonstrates daclizumab’s positive cognitive outcomes and safety profile in patients with relapsing-remitting multiple sclerosis (RRMS)...
22 April 2016 | By Victoria White, Digital Content Producer
Allergan has acquired Topokine Therapeutics for an upfront payment of $85 million and success-based development and sales milestones for XAF5...
22 April 2016 | By Victoria White, Digital Content Producer
NICE has issued final guidance recommending Sanofi’s Jevtana (cabazitaxel) for some prostate cancer patients...
21 April 2016 | By Victoria White, Digital Content Producer
A Phase III study shows that 52 percent of Nplate patients achieved a durable platelet response, compared with 10 percent of placebo-treated patients...
21 April 2016 | By The UK BioIndustry Association (BIA)
The UK BioIndustry Association has urged the US Supreme Court to review a decision of a lower court that could hinder the development of new diagnostics and medicines...
21 April 2016 | By Victoria White, Digital Content Producer
RedHill Biopharma has concluded a positive Type B Meeting with the FDA regarding the path to marketing approval of RHB-105...
21 April 2016 | By Victoria White, Digital Content Producer
Novo Nordisk has announced that it plans to invest more than 100 million euros in production facilities at its site in Chartres, France...
21 April 2016 | By Victoria White, Digital Content Producer
Results from a Phase III study show Novartis’ Afinitor (everolimus), when used as an adjunctive therapy, significantly reduced treatment-resistant seizures...
20 April 2016 | By Victoria White, Digital Content Producer
Pfizer has announced positive top-line results from the Phase III PALOMA-2 trial for Ibrance (palbociclib) in breast cancer...
